A large-scale proteomic analysis of human embryonic stem cells

BackgroundMuch of our current knowledge of the molecular expression profile of human embryonic stem cells (hESCs) is based on transcriptional approaches. These analyses are only partly predictive of protein expression however, and do not shed light on post-translational regulation, leaving a large gap in our knowledge of the biology of pluripotent stem cells.ResultsHere we describe the use of two large-scale western blot assays to identify over 600 proteins expressed in undifferentiated hESCs, and highlight over 40 examples of multiple gel mobility variants, which are suspected protein isoforms and/or post-translational modifications. Twenty-two phosphorylation events in cell signaling molecules, as well as potential new markers of undifferentiated hESCs were also identified. We confirmed the expression of a subset of the identified proteins by immunofluorescence and correlated the expression of transcript and protein for key molecules in active signaling pathways in hESCs. These analyses also indicated that hESCs exhibit several features of polarized epithelia, including expression of tight junction proteins.ConclusionOur approach complements proteomic and transcriptional analysis to provide unique information on human pluripotent stem cells, and is a framework for the continued analyses of self-renewal.

[1]  N. Perrimon,et al.  Apicobasal polarization: epithelial form and function. , 2003, Current opinion in cell biology.

[2]  M. Welham,et al.  Regulation of Embryonic Stem Cell Self-renewal by Phosphoinositide 3-Kinase-dependent Signaling* , 2004, Journal of Biological Chemistry.

[3]  T. Schulz,et al.  Directed neuronal differentiation of human embryonic stem cells , 2003, BMC Neuroscience.

[4]  M. Brownlee,et al.  Nonenzymatic glycosylation in vitro and in bovine endothelial cells alters basic fibroblast growth factor activity. A model for intracellular glycosylation in diabetes. , 1994, The Journal of clinical investigation.

[5]  H. Schöler,et al.  Formation of Pluripotent Stem Cells in the Mammalian Embryo Depends on the POU Transcription Factor Oct4 , 1998, Cell.

[6]  A. Citri,et al.  The deaf and the dumb: the biology of ErbB-2 and ErbB-3. , 2003, Experimental cell research.

[7]  Hossein Baharvand,et al.  Proteomic signature of human embryonic stem cells , 2006, Proteomics.

[8]  Ariel J. Levine,et al.  TGFβ/activin/nodal signaling is necessary for the maintenance of pluripotency in human embryonic stem cells , 2005 .

[9]  S. Pelech,et al.  Kinetworks protein kinase multiblot analysis. , 2003, Methods in molecular biology.

[10]  A. Maitra,et al.  Characterization of a New NIH‐Registered Variant Human Embryonic Stem Cell Line, BG01V: A Tool for Human Embryonic Stem Cell Research , 2006, Stem cells.

[11]  J. Thomson,et al.  Basic FGF and suppression of BMP signaling sustain undifferentiated proliferation of human ES cells , 2005, Nature Methods.

[12]  J. Thomson,et al.  Embryonic stem cell lines derived from human blastocysts. , 1998, Science.

[13]  C. Gilles,et al.  Epithelial-mesenchymal transition process in human embryonic stem cells cultured in feeder-free conditions. , 2007, Molecular human reproduction.

[14]  Dennis van Hoof,et al.  Concise Review: Trends in Stem Cell Proteomics , 2007, Stem cells.

[15]  R. Pedersen,et al.  Activin/Nodal and FGF pathways cooperate to maintain pluripotency of human embryonic stem cells , 2005, Journal of Cell Science.

[16]  M. Rao.  Conserved and divergent paths that regulate self-renewal in mouse and human embryonic stem cells. , 2004, Developmental biology.

[17]  R. Passier,et al.  A Quest for Human and Mouse Embryonic Stem Cell-specific Proteins *S , 2006, Molecular & Cellular Proteomics.

[18]  A. Brivanlou,et al.  Molecular signature of human embryonic stem cells and its comparison with the mouse. , 2003, Developmental biology.

[19]  A. Pyle,et al.  Defining the Role of Wnt/β‐Catenin Signaling in the Survival, Proliferation, and Self‐Renewal of Human Embryonic Stem Cells , 2005, Stem cells.

[20]  R. Puri,et al.  Properties of Pluripotent Human Embryonic Stem Cells BG01 and BG02 , 2004, Stem cells.

[21]  Tamar Dvash,et al.  Temporal gene expression during differentiation of human embryonic stem cells and embryoid bodies. , 2004, Human reproduction.

[22]  Takumi Miura,et al.  Monitoring early differentiation events in human embryonic stem cells by massively parallel signature sequencing and expressed sequence tag scan. , 2004, Stem cells and development.

[23]  R. Puri,et al.  Gene expression in human embryonic stem cell lines: unique molecular signature. , 2004, Blood.

[24]  H. Deng,et al.  A novel chemical-defined medium with bFGF and N2B27 supplements supports undifferentiated growth in human embryonic stem cells. , 2006, Biochemical and biophysical research communications.

[25]  I. Khrebtukova,et al.  MPSS profiling of human embryonic stem cells , 2004, BMC Developmental Biology.

[26]  Ying Liu,et al.  Assessing Self‐Renewal and Differentiation in Human Embryonic Stem Cell Lines , 2006, Stem cells.

[27]  A. Smith,et al.  Self-renewal of pluripotent embryonic stem cells is mediated via activation of STAT3. , 1998, Genes & development.

[28]  Ryan T Rodriguez,et al.  Unique gene expression signatures of independently-derived human embryonic stem cell lines. , 2004, Human molecular genetics.

[29]  G. Nau,et al.  Src Family Kinase Activity Is Required for Murine Embryonic Stem Cell Growth and Differentiation , 2005, Molecular Pharmacology.

[30]  A. Pébay,et al.  Gap junctions modulate apoptosis and colony growth of human embryonic stem cells maintained in a serum-free system. , 2006, Biochemical and biophysical research communications.

[31]  P. Greengard,et al.  Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor , 2004, Nature Medicine.

[32]  W. Freed,et al.  Karyotypic stability, genotyping, differentiation, feeder-free maintenance, and gene expression sampling in three human embryonic stem cell lines derived prior to August 9, 2001. , 2004, Stem cells and development.

[33]  J. Itskovitz‐Eldor,et al.  Feeder Layer- and Serum-Free Culture of Human Embryonic Stem Cells1 , 2004, Biology of reproduction.

[34]  M. Welsh,et al.  Segregation of receptor and ligand regulates activation of epithelial growth factor receptor , 2003, Nature.

[35]  J. Thomson,et al.  Derivation of human embryonic stem cells in defined conditions , 2006, Nature Biotechnology.

[36]  P. Brown,et al.  Gene expression patterns in human embryonic stem cells and human pluripotent germ cell tumors , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[37]  Ariel J. Levine,et al.  TGFbeta/activin/nodal signaling is necessary for the maintenance of pluripotency in human embryonic stem cells. , 2005, Development.

[38]  Ying Liu,et al.  Genome wide profiling of human embryonic stem cells (hESCs), their derivatives and embryonal carcinoma cells to develop base profiles of U.S. Federal government approved hESC lines , 2006, BMC Developmental Biology.

[39]  M. Beal,et al.  Functional engraftment of human ES cell–derived dopaminergic neurons enriched by coculture with telomerase-immortalized midbrain astrocytes , 2006, Nature Medicine.

[40]  E. Kroon,et al.  Production of pancreatic hormone–expressing endocrine cells from human embryonic stem cells , 2006, Nature Biotechnology.

[41]  M. Richards,et al.  The Transcriptome Profile of Human Embryonic Stem Cells as Defined by SAGE , 2004, Stem cells.

[42]  Sheng Ding,et al.  Long-term self-renewal and directed differentiation of human embryonic stem cells in chemically defined conditions. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[43]  C. Mummery,et al.  Embryonic stem cell proteomics , 2006, Expert review of proteomics.

[44]  W. Freed,et al.  BG01V: a variant human embryonic stem cell line which exhibits rapid growth after passaging and reliable dopaminergic differentiation. , 2004, Restorative neurology and neuroscience.

[45]  Michael P. Snyder,et al.  Defined culture conditions of human embryonic stem cells. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[46]  J. Itskovitz‐Eldor,et al.  Differences between human and mouse embryonic stem cells. , 2004, Developmental biology.

[47]  D. Payan,et al.  TNIK, a Novel Member of the Germinal Center Kinase Family That Activates the c-Jun N-terminal Kinase Pathway and Regulates the Cytoskeleton* , 1999, The Journal of Biological Chemistry.

[48]  S. Fisher,et al.  Serum-free derivation of human embryonic stem cell lines on human placental fibroblast feeders. , 2005, Fertility and sterility.

[49]  L. Hyslop,et al.  The role of PI3K/AKT, MAPK/ERK and NFkappabeta signalling in the maintenance of human embryonic stem cell pluripotency and viability highlighted by transcriptional profiling and functional analysis. , 2006, Human molecular genetics.

[50]  K. Kariya,et al.  The Traf2- and Nck-interacting Kinase as a Putative Effector of Rap2 to Regulate Actin Cytoskeleton* , 2004, Journal of Biological Chemistry.

[51]  W. Freed,et al.  Dopaminergic Differentiation of Human Embryonic Stem Cells , 2004, Stem cells.

[52]  P. Lorenz,et al.  From transcriptome to proteome: Differentially expressed proteins identified in synovial tissue of patients suffering from rheumatoid arthritis and osteoarthritis by an initial screen with a panel of 791 antibodies , 2003, Proteomics.